Postoperative VEGF and Recurrence After Colon Cancer Surgery
- Conditions
- AngiogenesisColon CancerSurgeryVEGF OverexpressionRecurrence
- Interventions
- Procedure: Surgery for colon cancer with intention to cure
- Registration Number
- NCT04851054
- Lead Sponsor
- Hospital del Mar
- Brief Summary
The purpose of this trial is to study the relationship between the angiogenic response to surgical aggression, determined through the serum levels of vascular endothelial growth factor (VEGF) on postoperative day four, and the tumor recurrence in patients with colon cancer operated with a curative intention.
- Detailed Description
DESIGN: Prospective multicentric study.
PARTICIPATION: Colorectal Surgery Units of Hospital del Mar, Barcelona; Hospital Universitari Joan XXIII, Tarragona; Hospital Universitari La Fe, Valencia; Hospital Clínico San Carlos, Madrid; Hospital General de Granollers, Granollers; Hospital Germans Trias i Pujol, Badalona; Athalaia, Xarxa Assistencial Universitària de Manresa, Manresa
STUDY SUBJECTS: 280 consecutive patients with non-metastatic colon cancer in whom a curative intent resection is performed.
DETERMINATIONS: Determination of the proangiogenic cytokine VEGF in serum on the postoperative day four to assess its relationship with oncological results on long-term follow-up.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 280
- Patients with colon cancer admitted to the Colorectal Surgery Unit of the centers participating in the study,
- Patients who will undergo elective surgical resection with potentially curative intention
- Patients with metastatic disease
- Patients with synchronous colon neoplasia or in the previous five years
- Patients undergoing emergency surgery
- Patients who do not sign the informed consent.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Patients after surgery for colon cancer with intention to cure Surgery for colon cancer with intention to cure Patients with colon cancer admitted to the Colorectal Surgery Unit of the centers participating in the study, who will undergo elective surgical resection with potentially curative intention
- Primary Outcome Measures
Name Time Method VEGF in serum on postop day 4 Postoperative day 4 A 10cc sample of peripheral blood will be drawn on postoperative day 4
- Secondary Outcome Measures
Name Time Method